1.PRoFESS - a 2x2 factorial, randomised, double blind, double dummy, global, active/placebo controlled trial of treatment designed to prevent second stroke in patients with fully diagnosed prior stroke or transient ischemic attack within the previous 120 days. PRoFESS is the first trial to attempt, by managing BP, to investigate a potential blood-pressure-independent mechanism and prevent thrombotic episodes in patients with established cerebrovascular disease. - Boehringer Ingelheim International
- Corporate Medical Division
- Binger Strasse 173
- 55216 Ingelheim am Rhein, Germany
2.VITATOPS - A Study of Vitamins TO Prevent Stroke - a multi-center, randomised, double-blind, placebo-controlled, clinical trial examining the efficacy and safety of multi-vitamin therapy in secondary stroke prevention.
- VITATOPS Trial Office
- Stroke Unit Research
- Royal Perth Hospital
- GPO Box X2213 Perth WA
- Australia 6847
3.TOPMAT - PEP - 3001- a Randomized, Double Blind, Placebo-Controlled, Fixed Dose-Ranging Study. Evaluate the safety and efficacy of Topiramate in children with partial-onset seizure disorder 1 to 23 months old, using both a liquid form and the sprinkle form of the drug. This study will also compare the effect of the medicine in 3 different dosages against placebo in children who are also taking 1 or 2 other anticonvulsant drugs for their seizures.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C
|
